Literature DB >> 24639148

Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis.

Stephanie Misono1, Schelomo Marmor, Bevan Yueh, Beth A Virnig.   

Abstract

BACKGROUND: The objectives of this study were to identify factors associated with treatment differences, characterize changes in treatment patterns over time, and compare survival across treatment types in patients who received treatment for localized laryngeal cancer.
METHODS: Using the Surveillance, Epidemiology, and End Results database, we conducted a retrospective cohort analysis of patients who were treated from 1995 to 2009 for localized laryngeal cancer. Four treatment groups were defined: (1) radiation only, (2) local surgery only, (3) local surgery and radiation, and (4) open surgery with or without radiation. Variations in treatment rates between these groups were evaluated according to demographic factors, and differences in treatment rates across time were calculated. Associations between treatment and mortality were assessed using Kaplan-Meier methods. Cox proportional hazards regression models were used to adjust for potential confounding covariates.
RESULTS: In total, 10,429 patients with localized laryngeal cancer were identified. Most patients (57%) were treated with radiation only; 25% with local surgery and radiation, 9% with local surgery only, and 9% with open surgery with or without radiation. Race, age, and registry were associated with differences in treatment. Receipt of single-modality treatment increased and receipt of combined-modality treatment decreased over the study period. Better survival was observed with white race, younger age, and treatment with local surgery. Survival differences associated with treatment type were observed within 3 years of diagnosis and persisted beyond 5 years after diagnosis.
CONCLUSIONS: Although treatment patterns became more adherent to treatment guidelines over time, we identified survival differences associated with treatment type that warrant further investigation into treatment decision-making for patients with localized laryngeal cancer.
© 2014 American Cancer Society.

Entities:  

Keywords:  End Results Program; Epidemiology; Surveillance; laryngeal cancer; operative procedures; radiation; survival; voice

Mesh:

Year:  2014        PMID: 24639148      PMCID: PMC5560918          DOI: 10.1002/cncr.28608

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

Review 1.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  Impact of treating facilities' volume on survival for early-stage laryngeal cancer.

Authors:  Amy Y Chen; Alex Pavluck; Michael Halpern; Elizabeth Ward
Journal:  Head Neck       Date:  2009-09       Impact factor: 3.147

Review 4.  Radiotherapeutic management of laryngeal carcinoma.

Authors:  Boris Hristov; Gopal K Bajaj
Journal:  Otolaryngol Clin North Am       Date:  2008-08       Impact factor: 3.346

Review 5.  Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy.

Authors:  Kevin M Higgins; Manish D Shah; Maurice J Ogaick; Danny Enepekides
Journal:  J Otolaryngol Head Neck Surg       Date:  2009-12

6.  What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?

Authors:  Kevin M Higgins
Journal:  Laryngoscope       Date:  2011-01       Impact factor: 3.325

7.  Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.

Authors:  Reshma Jagsi; Paul Abrahamse; Sarah T Hawley; John J Graff; Ann S Hamilton; Steven J Katz
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

8.  Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.

Authors:  Hong Zhang; Lois B Travis; Rui Chen; Ollivier Hyrien; Michael T Milano; Shawn D Newlands; Yuhchyau Chen
Journal:  Cancer       Date:  2011-07-19       Impact factor: 6.860

9.  A population-based study of therapy and survival for patients with head and neck cancer treated in the community.

Authors:  Claudio Dansky Ullmann; Linda C Harlan; Vickie L Shavers; Jennifer L Stevens
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

10.  Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.

Authors:  Todd M Tuttle; Stephanie Jarosek; Elizabeth B Habermann; Amanda Arrington; Anasooya Abraham; Todd J Morris; Beth A Virnig
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

View more
  15 in total

Review 1.  Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.

Authors:  Matthew T Greulich; Noah P Parker; Philip Lee; Albert L Merati; Stephanie Misono
Journal:  Otolaryngol Head Neck Surg       Date:  2015-04-02       Impact factor: 3.497

2.  Heat and moisture exchanger cassettes: Results of a quality/safety initiative to reduce postoperative mucus plugging after total laryngectomy.

Authors:  Barbara Ebersole; Kathleen Moran; Jiangtao Gou; John Ridge; Linda Schiech; Jeffrey C Liu; Miriam Lango
Journal:  Head Neck       Date:  2020-05-23       Impact factor: 3.147

3.  Characteristics and outcome of laryngeal squamous cell carcinoma in young adults.

Authors:  Yuval Nachalon; Ohad Cohen; Uri Alkan; Jacob Shvero; Aron Popovtzer
Journal:  Oncol Lett       Date:  2016-12-21       Impact factor: 2.967

4.  Epidemiological, clinical and oncological outcomes of young patients with laryngeal cancer: a systematic review.

Authors:  Giuditta Mannelli; Carlos M Chiesa-Estomba; Jérôme R Lechien; Antonino Maniaci; Stéphane Hans; Giannicola Iannella; Nicolas Fakhry; Miguel Mayo-Yáñez; Tareck Ayad
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-02       Impact factor: 2.503

5.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

6.  Practice variations in voice treatment selection following vocal fold mucosal resection.

Authors:  Jaime E Moore; Paul J Rathouz; Jeffrey A Havlena; Qianqian Zhao; Seth H Dailey; Maureen A Smith; Caprice C Greenberg; Nathan V Welham
Journal:  Laryngoscope       Date:  2016-03-12       Impact factor: 3.325

7.  The role of primary surgical treatment in young patients with squamous cell carcinoma of the larynx: a 20-year review of 34 cases.

Authors:  Junxi Wang; Xingguo Zhao; Xinliang Pan; Limin Zhao; Jianming Zhou; Min Ji
Journal:  World J Surg Oncol       Date:  2015-09-24       Impact factor: 2.754

8.  T1 glottic carcinoma: do comorbidities, facility characteristics, and sociodemographics explain survival differences across treatment?

Authors:  Stephanie Misono; Schelomo Marmor; Bevan Yueh; Beth A Virnig
Journal:  Otolaryngol Head Neck Surg       Date:  2015-02-24       Impact factor: 3.497

9.  First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.

Authors:  Xin Wang; Elizabeth A Mauer; Paul Christos; Julia Manzerova; A Gabriella Wernicke; Bhupesh Parashar
Journal:  Cureus       Date:  2017-05-29

10.  Unravelling the risk factors that underlie laryngeal surgery in elderly.

Authors:  E Crosetti; A Caracciolo; G Molteni; A E Sprio; G N Berta; L Presutti; G Succo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.